Previous 10 | Next 10 |
Endo (ENDP): Q3 Non-GAAP EPS of $0.52 beats by $0.38; GAAP EPS of -$0.30 beats by $0.22.Revenue of $634.86M (-13.0% Y/Y) beats by $84.23M.CF Ops: $77M (+133.3%).2020 guidance: Revenues: $2.75B-$2.80B from previous guidance of $2.60B-$2.70B vs. $2.7B Consensus; non-GAAP EPS: ...
Endo Reports Third-Quarter 2020 Financial Results And Raises Full Year 2020 Financial Guidance PR Newswire DUBLIN, Nov. 5, 2020 DUBLIN , Nov. 5, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the third-qu...
Endo Announces Strategic Actions to Further Position the Company for Long-Term Success PR Newswire DUBLIN, Nov. 5, 2020 - Initiatives to Enable Company to Reinvest in Key Areas of Growth - DUBLIN , Nov. 5, 2020 /PRNewswire/ -- Endo International plc (...
[[AAXN]], [[ACLS]], [[ADT]], [[AGO]], [[AIG]], [[AINV]], [[ALRM]], [[ALTR]], [[AMCR]], [[AMH]], [[AMN]], [[ANGI]], [[APPN]], [[ATGE]], [[ATRC]], [[AVLR]], [[AYX]], [[AZPN]], [[BFAM]], [[BGS]], [[BHF]], [[BIGC]], [[BILL]], [[BKNG]], [[BLDP]], [[BMRN]], [[BNFT]], [[CABO]], [[CARG]], [[CDAY]], [...
Isofol Medical has entered into a license agreement with Endo Ventures Limited, a subsidiary of Endo International ([[ENDP]] -3.8%), for the exclusive registration and commercialization of arfolitixorin in Canada. Endo's operating company, Paladin Labs will be responsible ...
Envarsus® PA Once-daily Immunosuppressive Therapy for Kidney and Liver Transplant Patients is Now Reimbursed in Ontario, Quebec, Manitoba and Saskatchewan Canada NewsWire MONTREAL, Oct. 22, 2020 MONTREAL , Oct. 22, 2020 /CNW/ -- Paladin Labs Inc...
BRIDGEWATER, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Nevakar Inc., a biopharmaceutical company developing multiple assets in the ophthalmic and injectable areas, announced today it received approval from the U.S. Food and Drug Administration (FDA) to market Ephedrine Sulfate Injection in a ...
Privately held Purdue Pharma, the corporate poster child in the opioid epidemic due to its aggressive promotion of pain pill OxyContin, has agreed to plead guilty to three criminal charges under an $8B settlement with the U.S. Department of Justice the Associated Press reports.The three count...
Shares of Endo International (NASDAQ: ENDP) and BioSpecifics Technologies (NASDAQ: BSTC) were soaring 13.9% and 45.1%, respectively, as of 3:31 p.m. EDT on Monday. The big gains came after Endo announced plans to acquire BioSpecifics Technologies for $540 million net of cash...
Endo International (ENDP) has agreed to acquire all of the outstanding shares of BioSpecifics Technologies (BSTC) for $88.50 per share in cash, representing an aggregate equity value of ~$540M (net of ~$120M in cash acquired).Under the terms of the merger agreement, Endo through a ...
News, Short Squeeze, Breakout and More Instantly...
Endo International plc Company Name:
ENDP Stock Symbol:
NASDAQ Market:
Endo International plc Website:
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Canada NewsWire DUBLIN , Sept. 21, 2023 /CNW/ -- Endo International plc (OTC:...
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS Canada NewsWire DUBLIN , Aug. 8, 2023 /CNW/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the second-quarter ended June 30, 2023 . SECOND-QUARTER FINANCIAL PERF...
Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe Canada NewsWire The ready-to-use pre-filled syringe combines two well-known, FDA-approved product...